- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Maraviroc – November 2009
Maraviroc, tablets, 150 mg and 300 mg, Celsentri®, November 2009
Last updated
5 March 2010